Agios Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
16.02.24
/
50%
€24.80
Target price
16.02.25
€38.99
Performance (%)
40.32%
Price
30.05.24
€34.80
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Agios Pharmaceuticals Inc. has seen massive gains of 40.32%. This prediction currently runs until 16.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Agios Pharmaceuticals Inc. | 10.828% | 10.828% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target lowered by analysts at Royal Bank of Canada from $43.00 to $42.00. They now have an "outperform" rating on the stock.
Ratings data for AGIO provided by MarketBeat